Alfred Yellson

Bachelor of Medicine and Bachelor of Science,  Mayo Clinic - Rochester 

Location: Africa

Consulting Services

Legal Support Sales and Marketing Admin and Customer Support Hospital-Pharmacy-Insurance

Areas Of Interest

Subject, Human Transcription Activator Like Effector Nucleases Normalities Reticulum-Cell Sarcomas Neovascularization, Pathologic c bcl 1 Proteins TRAIL Receptor 2 Population Policy Third-World Countries Patterns, Inheritance Fibers, Intermediate Muscle Intra-Observer Variability Endoglucanase Micrasteria Eradications, Disease Transcription Factor PAX3 Monohydrochloride, Rolitetracycline Radionuclide Angiocardiographies, Equilibrium Pathologic Neovascularization NADH GOGAT Religious Ethics Ischemias, Mesenteric Alrheumat Cryopyrinopathies Bronchiolitides Outsourced Service Trophoblastic Tumors, Placental-Site Embryo Reductions Chemistry, Clinical Sexual Precocities Residential Selections Receptor, Pancreatic Hormone Doxazosin Klast Eastern Equine Encephalomyelitides Circulation, Extracorporeal Polyethylene Glycol Monododecyl Ether

Professional Narrative

Dr. Alfred Yellson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Yellson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.

Employment

Medical Writer, Harvard Med 2011
Director Medicine, Harvard Med 2017

Education

Bachelor of science in nursing, Perelman School of Medicine 2006
Master of Science in physician assistant, Harvard Medical School 2018

Referees

Publications

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :

Languages

Language Proficiency :

Translation Services :

Serving Millions of physicians and biomedical scientists in Industry and academia.

Site
Services
Follow Us
Contact Us
  • support@scienceandminds.com

Copyright © 2025 Trialect Inc. All rights reserved. | v2023.06.17.02